<DOC>
	<DOCNO>NCT00294671</DOCNO>
	<brief_summary>The purpose study determine diflunisal prevent progressive low leg nerve damage patient familial amyloidosis polyneuropathy . Funding Source - FDA Office Orphan Products Development ( OOPD ) ; National Institute Neurological Disorders Stroke ( NINDS )</brief_summary>
	<brief_title>The Effect Diflunisal Familial Amyloidosis</brief_title>
	<detailed_description>Familial amyloidosis polyneuropathy ( FAP ) rare , lethal , autosomal dominant , neurodegenerative disease characterize misfolding variant transthyretin tetramer ( TTR ) â€” transport protein produce liver . The disease cause TTR become unstable , trigger amyloid fibril form lead peripheral autonomic nerve dysfunction . Currently , treatment FAP liver transplant , expensive risk-filled . Medicines need treat disease . Previous vitro ( test tube ) study show common anti-inflammatory drug call diflunisal stabilize TTR , prevent formation amyloid fibril . The goal 2-year randomize , double-blind , placebo-controlled research study establish whether diflunisal stop nerve damage , peripheral neuropathy , result amyloid production patient FAP . Scientists already know diflunisal prevents formation amyloid test tube . This study determine drug block amyloid production FAP patient . Participants randomly choose receive either diflunisal inactive ( placebo ) pill twice daily 24 month . Participants carefully monitor 7 follow-up visit , either study center individual primary care physician . Participating study preclude patient list liver transplantation .</detailed_description>
	<mesh_term>Amyloidosis</mesh_term>
	<mesh_term>Polyneuropathies</mesh_term>
	<mesh_term>Amyloid Neuropathies</mesh_term>
	<mesh_term>Amyloid Neuropathies , Familial</mesh_term>
	<mesh_term>Amyloidosis , Familial</mesh_term>
	<mesh_term>Diflunisal</mesh_term>
	<criteria>Age 18 75 year Biopsy proven amyloidosis Genotyping variant transthyretin Signs peripheral autonomic neuropathy Use nonsteroidal antiinflammatory drug Other cause sensorimotor polyneuropathy Anticipated survival &lt; 2 year liver transplantation &lt; 1 yr Liver transplantation Profound nerve , heart kidney impairment Pregnancy unwillingness use contraception woman childbearing age Active recent gastrointestinal bleeding Nonsteroidal aspirin drug allergy/hypersensitivity</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>familial amyloid polyneuropathy</keyword>
	<keyword>familial amyloidosis</keyword>
	<keyword>diflunisal</keyword>
	<keyword>amyloidosis</keyword>
	<keyword>transthyretin</keyword>
	<keyword>peripheral neuropathy</keyword>
	<keyword>autonomic neuropathy</keyword>
	<keyword>amyloid cardiomyopathy</keyword>
</DOC>